Harrow Health (HROW) Tops Q2 EPS by 12c
Tweet
Share
E-mailHarrow Health (NASDAQ: HROW) reported Q2 EPS of ($0.06), $0.12 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $48.94 million versus the consensus estimate of $42.51 million.
For earnings history and earnings-related data on Harrow Health (HROW) click here.
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
